Role of Pharmacists in Optimizing Medication Adherence Through Patient Education and Counseling in Chronic Disease Management
DOI:
https://doi.org/10.22399/ijcesen.4567Keywords:
Pharmacists, medication adherence, patient education, counseling, chronic disease management, diabetesAbstract
Pharmacists play an essential role in optimizing medication adherence, especially in the context of managing chronic diseases such as diabetes, hypertension, and asthma. By acting as accessible healthcare providers, pharmacists can offer personalized education and counseling to patients at various points in their care journey. This includes explaining the importance of medication adherence, reviewing potential side effects, and clarifying dosing schedules. Such interventions not only empower patients with the knowledge to manage their conditions effectively but also foster a teamwork approach to health care, where pharmacists collaborate with physicians and other healthcare professionals to ensure a comprehensive management strategy that addresses patient needs and preferences. In addition to providing medication-related education, pharmacists are crucial in identifying barriers to adherence, such as cost issues, complex regimens, or misunderstandings about the therapeutic goals. Through one-on-one counseling sessions, they can tailor solutions like medication synchronization, blister packaging, or referral to financial assistance programs. The ongoing support provided by pharmacists can significantly enhance a patient's commitment to their treatment plan, leading to improved health outcomes and reduced healthcare costs associated with complications stemming from non-adherence. By fostering a supportive relationship and creating a safe space for patients to voice concerns, pharmacists effectively bridge the gap between medication prescriptions and real-world patient behaviors.
References
[1] DuBard CA. Savings impact of Community Care of North Carolina: a review of the evidence. Community Care of North Carolina. Data Brief. Issue no. 11. July 27, 2017.
[2] Centers for Medicare & Medicaid Services. How MIPS eligibility is determined.
[3] American College of Physicians. ACO or PCMH: making a crucial decision for your practice. Medical Economics. February 4, 2015.
[4] Ifeanyi Chiazor E, Evans M, van Woerden H, Oparah AC. A systematic review of community pharmacists’ interventions in reducing major risk factors for cardiovascular disease. Value Health Reg Issues. 2015;7:9-21.
[5] Farris KB, Ashwood D, McIntosh J, et al. Preventing unintended pregnancy: pharmacists’ roles in practice and policy via partnerships. J Am Pharm Assoc (2003). 2010;50(5):604-12.
[6] Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother. 2018;52(9):829-37.
[7] Brown TJ, Todd A, O’Malley C, et al. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open. 2016;6(2):e009828.
[8] Luder HR, Shannon P, Kirby J, Frede SM. Community pharmacist collaboration with a patient-centered medical home: establishment of a patient-centered medical neighborhood and payment model. J Am Pharm Assoc (2003). 2018;58(1):44-50.
[9] Gomez A. Availability of pharmacist-prescribed contraception in California, 2017. JAMA. 2017;318(22):2253-54.
[10] Centers for Medicare & Medicaid Services. 2017 star ratings. Fact sheet. October 12, 2016.
[11] San-Juan-Rodriguez A, Newman TV, Hernandez I, et al. Impact of community pharmacist-provided preventive services on clinical, utilization, and economic outcomes: an umbrella review. Prev Med. 2018;115:145-55.
[12] Avalere Health. Developing trends in delivery and reimbursement of pharmacist services. November 2015.
[13] Rosenbaum L, Shrank WH. Taking our medicine—improving adherence in the accountability era. N Engl J Med. 2013;369(8):694-95.
[14] Centers for Medicare & Medicaid Services. MACRA. Updated June 14, 2019.
[15] Altowaijri A, Phillips CJ, Fitzsimmons D. A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm. 2013;19(5):408-16.
[16] Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc (2003). 2008;48(2):203-14.
[17] Mossialos E, Courtin E, Naci H, et al. From “retailers” to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy. 2015;119(5):628-39.
[18] Bonner L. A whirlwind tour of value-based payment models—with pharmacists as your guide. Pharmacy Today. 2018;24(6):38-39.
[19] Abrams K, Balan-Cohen A, Durbha P. Growth in outpatient care: the role of quality and value incentives. Deloitte Insights. August 15, 2018.
[20] Prudencio J, Cutler T, Roberts S, Marin S, Wilson M. The effect of clinical pharmacist-led comprehensive medication management on chronic disease state goal attainment in a patient-centered medical home. J Manag Care Spec Pharm. 2018;24(5):423-29.
[21] Blalock SJ, Roberts AW, Lauffenburger JC, Thompson T, O’Connor SK. The effect of community pharmacy-based interventions on patient health outcomes: a systematic review. Med Care Res Rev. 2013;70(3):235-66.
[22] Burton D, Haughom J. What is an accountable care organization (ACO)? Health Catalyst. April 17, 2014.
[23] Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005;27(7):1104-11.
[24] Duff BL. Pharmacists can help reduce repeat MIs. Drug Topics. September 12, 2017.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering
This work is licensed under a Creative Commons Attribution 4.0 International License.
